Computational pathology relies on image analysis software to extract data. DP workflows enable computational pathology, where the WSI is translated to data and applied mathematical models for a more precise interpretation and to enable research and discovery. The DP workflow encompasses a broad set of processes implemented in the pathology laboratory of which the DPS is a component. It consists of the scanner, software, and the image viewer. The DPS refers to the end-to-end components that result in the generation and viewing of digital WSI. The high-resolution digital WSI may be viewed on a computer, shared or stored. The WSI is acquired by scanning a glass slide with a whole slide scanner. Together, they will result in the delivery of valuable information from which to make better decisions and improve the health of patients.Ī few definitions may be confusing and thus used interchangeably: Whole slide image (WSI), digital pathology (DP), DP system (DPS), DP workflow, telepathology, and computational pathology.Īt its core, DP is based on capturing a high-resolution digital replica of a conventional glass slide, called a WSI. Digital pathology will change the way we practice through facilitating patient access to expert pathology services and enabling image analysis tools and assays to aid in diagnosis, prognosis, risk stratification and therapeutic selection. Contributors to this paper analyzed peer-reviewed literature and data collected from various institutions, some of which are mentioned. The authors encourage readers who are evaluating conversion to a DP workflow to use this paper as a foundational guide for conducting a thorough and complete assessment while incorporating in current market pricing. It is important to clarify that this publication is not intended to list prices although some financials will be mentioned as examples.
#Digital pathology how to
The components of a DP business plan will be thoroughly summarized, and guidance will be provided on how to build a case for adoption and implementation as well as a roadmap for transitioning from an analog to a digital pathology workflow in various laboratory settings. The focus of this whitepaper is to educate pathologists, laboratorians and other stakeholders about the business and monetary considerations of converting to a digital pathology workflow. Many aspects of the adoption of DP will be disruptive and have a direct financial impact, both in short term costs, such as investment in equipment and personnel, and long term revenue potential, such as improved productivity and novel tests. We believe the switch to a digital pathology (DP) workflow is imminent and it is essential to understand the economic implications of conversion.
0 kommentar(er)
